These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 33438085)
21. Is there an association between the plasma levels of uremic toxins from gut microbiota and anemia in patients on hemodialysis? Capo-Chichi JCC; Borges NA; de Vargas Reis DCM; Nakao LS; Mafra D Int Urol Nephrol; 2022 Jun; 54(6):1271-1277. PubMed ID: 34561817 [TBL] [Abstract][Full Text] [Related]
22. Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients? Eloot S; Van Biesen W; Glorieux G; Neirynck N; Dhondt A; Vanholder R PLoS One; 2013; 8(11):e76838. PubMed ID: 24236005 [TBL] [Abstract][Full Text] [Related]
23. Synbiotic meal decreases uremic toxins in hemodialysis individuals: A placebo-controlled trial. Lopes RCSO; Theodoro JMV; da Silva BP; Queiroz VAV; de Castro Moreira ME; Mantovani HC; Hermsdorff HH; Martino HSD Food Res Int; 2019 Feb; 116():241-248. PubMed ID: 30716942 [TBL] [Abstract][Full Text] [Related]
24. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique. Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821 [TBL] [Abstract][Full Text] [Related]
25. pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro. Yamamoto S; Sasahara K; Domon M; Yamaguchi K; Ito T; Goto S; Goto Y; Narita I Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33557434 [TBL] [Abstract][Full Text] [Related]
26. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients. Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155 [TBL] [Abstract][Full Text] [Related]
27. Can Resveratrol Supplementation Reduce Uremic Toxin Plasma Levels From the Gut Microbiota in Nondialyzed Patients With Chronic Kidney Disease? Alvarenga L; Cardozo LFMF; Leal VO; Kemp JA; Saldanha JF; Ribeiro-Alves M; Meireles T; Nakao LS; Mafra D J Ren Nutr; 2022 Nov; 32(6):685-691. PubMed ID: 35122992 [TBL] [Abstract][Full Text] [Related]
28. Exploring binding characteristics and the related competition of different protein-bound uremic toxins. Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271 [TBL] [Abstract][Full Text] [Related]
29. Determination of uremic solutes in biological fluids of chronic kidney disease patients by HPLC assay. Calaf R; Cerini C; Génovésio C; Verhaeghe P; Jourde-Chiche N; Bergé-Lefranc D; Gondouin B; Dou L; Morange S; Argilés A; Rathelot P; Dignat-George F; Brunet P; Charpiot P J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(23):2281-6. PubMed ID: 21727042 [TBL] [Abstract][Full Text] [Related]
30. Uremic toxins levels from the gut microbiota seem not to be altered by physical exercise in hemodialysis patients. de Brito JS; Vargas D; da Silva GS; Marinho S; Borges NA; Cardozo LFMF; Fonseca L; Ribeiro M; Chermut TR; Moura M; Regis B; Meireles T; Nakao LS; Mafra D Int Urol Nephrol; 2022 Mar; 54(3):687-693. PubMed ID: 34254218 [TBL] [Abstract][Full Text] [Related]
31. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial. Esgalhado M; Kemp JA; Azevedo R; Paiva BR; Stockler-Pinto MB; Dolenga CJ; Borges NA; Nakao LS; Mafra D Food Funct; 2018 Dec; 9(12):6508-6516. PubMed ID: 30468238 [TBL] [Abstract][Full Text] [Related]
32. Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study. Panichi V; Rocchetti MT; Scatena A; Rosati A; Migliori M; Pizzarelli F; Gesualdo L; J Nephrol; 2017 Aug; 30(4):583-591. PubMed ID: 28337716 [TBL] [Abstract][Full Text] [Related]
33. The Impact of CKD on Uremic Toxins and Gut Microbiota. Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343 [TBL] [Abstract][Full Text] [Related]
34. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them? Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928 [TBL] [Abstract][Full Text] [Related]
35. Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis. Chen X; Gao S; Ruan M; Chen S; Xu J; Xing X; Pan X; Mei C; Mao Z Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29921575 [TBL] [Abstract][Full Text] [Related]
36. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial. Sirich TL; Fong K; Larive B; Beck GJ; Chertow GM; Levin NW; Kliger AS; Plummer NS; Meyer TW; Kidney Int; 2017 May; 91(5):1186-1192. PubMed ID: 28089366 [TBL] [Abstract][Full Text] [Related]
37. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury. Veldeman L; Vanmassenhove J; Van Biesen W; Massy ZA; Liabeuf S; Glorieux G; Vanholder R Int Urol Nephrol; 2019 Feb; 51(2):293-302. PubMed ID: 30604232 [TBL] [Abstract][Full Text] [Related]
38. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis. Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673 [TBL] [Abstract][Full Text] [Related]
39. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112 [TBL] [Abstract][Full Text] [Related]
40. Differences in Dialysis Efficacy Have Limited Effects on Protein-Bound Uremic Toxins Plasma Levels over Time. Krieter DH; Kerwagen S; Rüth M; Lemke HD; Wanner C Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30654454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]